Since 2018, the government has invested £200 million in a national Vaccination Manufacturing and Innovation Centre. Under the auspices of three UK universities, the VMIC has been crucial in the rapid development and manufacture of the UK’s anti-Covid vaccine. Development of the Astrazeneca vaccine was 97% government funded. A brand new purpose-built VMIC centre is due to open shortly in the science park at Harwell, Oxfordshire. However, the government has put VMIC up for sale and a number of companies have expressed interest. In recent weeks articles about the sell-off have appeared in the Financial Times, Independent, and Tribune and Observer. Health professionals associated with the work of the VMIC strongly oppose the sale because in would undermine the capacity of the UK to prepare to combat virus epidemics and develop vaccines in the future.